3D printing takes step forward in creating human skin

3D printing, capable of producing heart models, concreate buildings and prosthetics, is still rapidly advancing. Researchers have developed 3D-printing technology capable of creating human-like skin.

Published in Biofabrication, the study showed the skin "can be transplanted to patients or used in business settings to test chemical products, cosmetics or pharmaceutical products in quantities and with timetables and prices that are compatible with these uses,” according to José Luis Jorcano, professor in UC3M's department of Bioengineering and Aerospace Engineering and head of the Mixed Unit CIEMAT/UC3M in Biomedical Engineering.

The human skin, a production of bioprinting, includes every layer from the natural structure of skin. From the epidermis to the dermis, the skin was made with bioinks and printed from a computer that builds the skin on a print bed. The process for making the tissue can be done two ways: allogeneric skin from a stock of cells for larger scale projects and autologous skin made from the patient’s own skin cells to treat severe burns.

"This method of bioprinting allows skin to be generated in a standardized, automated way, and the process is less expensive than manual production," said Alfredo Brisac, CEO of BioDan Group, a Spanish bioengineering firm specializing in regenerative medicine.

While it is still being approved by European regulatory agencies, the skin has potential to be used in transplants of burn patients and those with skin conditions as well as being used to test pharmaceutical products, cosmetics and chemical products and eliminating the need for the testing on animals.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup